Indegene Share Price Target 2027: Base and Bull Targets Built on FY26 Earnings

Investors weighing an Indegene target price for 2027 should start with where the stock sits today. At Rs 580.90 on 9 October 2026, it is 7.4% below its 52-week high of Rs 627.00 and 40.3% above its 52-week low of Rs 414.00. That range spans 51% from low to high, so the entry point matters as much as the Indegene price forecast itself.

This article builds the Indegene share price target from reported numbers only: five years of annual results, the last five quarters, the latest shareholding pattern and current valuation ratios from company filings and exchange data. Each scenario shows its assumptions, so you can see exactly how the Rs 615 base case and the Rs 748 bull case were reached, along with a downside risk level of Rs 469.

Click Here – Get Free Investment Predictions

Indegene Stock Analysis: Company Overview and Key Stats

Indegene (NSE: INDGN) has a market capitalisation of Rs 14,110 crore. In FY26 it reported revenue of Rs 3,582 crore and net profit of Rs 401.10 crore. The table collects the figures the Indegene share price target is built on.

Metric	Value
Company	Indegene
NSE Ticker	INDGN
CMP (9 October 2026)	Rs 580.90
52-Week High	Rs 627.00
52-Week Low	Rs 414.00
Market Cap	Rs 14,110 crore
PE Ratio (TTM)	35.20
Industry PE	62.79
Price to Book	4.50
Return on Equity	12.78%
Debt to Equity	0.05
EPS (TTM)	Rs 16.64
Dividend Yield	0.38%
12-Month Base Target	Rs 615
Bull Case	Rs 748
Downside Risk Level (not a target)	Rs 469

Why Is Indegene Share Price Target Set at Rs 615 for 2027?

The base-case Indegene stock target of Rs 615 applies a PE multiple of 35.20 to a forward EPS estimate of Rs 17.47. That EPS assumes 5.0% yearly growth, the pace from FY24 to FY26, and puts the target 5.9% above the current price. The bull case adds faster earnings growth and a higher multiple, while the downside risk level assumes flat earnings and a lower multiple.

Earnings Growth Behind the Indegene Target Price: Five Years of Results

Indegene grew revenue from Rs 1,690 crore in FY22 to Rs 3,582 crore in FY26, a compound annual growth rate of 20.7%. Net profit grew faster, from Rs 162.82 crore to Rs 401.10 crore (25.3% a year), which shows margin gains did part of the work and not just higher sales.

Financial Year	Revenue (Rs Cr)	Net Profit (Rs Cr)	EPS (Rs)	Dividend per Share (Rs)
FY22	1,690.50	162.82	7.50	0.00
FY23	2,364.10	266.10	11.97	0.00
FY24	2,665.90	336.70	15.07	0.00
FY25	2,946.50	406.70	17.02	2.00
FY26	3,582.50	401.10	16.62	2.25

FY26 revenue growth was 21.6%, close to the four-year average of 20.7%, and net profit moved down 1.4%. EPS rose from Rs 15.07 in FY24 to Rs 16.62 in FY26. The FY27 outlook depends on whether that EPS estimate keeps compounding.

Margins and the Latest Quarter

Indegene converted 11.2% of FY26 revenue into net profit, against 13.8% in FY25, within a five-year range of 9.6% to 13.8%. EBITDA margin was 18.7% in FY26 versus 21.8% in FY25.

In the June 2026 quarter, revenue was Rs 1,092 crore, up 39.5% from the same quarter a year earlier, while net profit of Rs 116.20 crore was down 0.2%. EBITDA came in at Rs 203.20 crore, up 14.5% year on year. The next quarterly result is the first test of whether the earnings assumption holds.

Balance Sheet and Cash Flow

Debt to equity stands at 0.05, and shareholders' equity grew from Rs 763.90 crore in FY22 to Rs 3,139 crore in FY26. Operating cash flow in FY26 was Rs 650.80 crore against capital expenditure of Rs 44.30 crore, leaving free cash flow of Rs 606.50 crore, or 4.3% of the current market capitalisation. In FY25 free cash flow was Rs 411.90 crore.

Valuation Check for the Indegene Stock Target: PE, Price to Book and ROE

At a PE of 35.20 against an industry PE of 62.79, Indegene trades at a discount to its industry. Price to book is 4.50 on a book value of Rs 130.27 per share, and return on equity is 12.78%. A PE of 35.20 equals an earnings yield of 2.8%, and the FY26 dividend of Rs 2.25 per share gives a yield of 0.38%.

Shareholding Pattern and Institutional Holding

The latest filing shows no promoter holding in Indegene, so ownership rests with institutions and public shareholders. Foreign institutional investors (FII) held 9.91% and domestic institutions (DII) held 8.74%, which puts total institutional holding at 18.65%. FII holding has stayed near 9.91% since June 2025. Public shareholders own the remaining 81.34%. A meaningful institutional holding adds a layer of research coverage and trading depth.

Indegene Share Price Targets for the Short Term and 12 Months

Short Term Indegene Stock Target Levels: Technical Setup

At Rs 580.90 on 9 October 2026, Indegene trades above its 50-day simple moving average of Rs 578.52 and above its 200-day exponential moving average of Rs 540.98. The 14-day RSI reads 41.9, which is neutral territory, and the MACD line sits below its signal line. The nearest resistance level is Rs 627.00 (52-week high) and the nearest support is Rs 578.52 (50-day simple moving average). A sustained move above Rs 627.00 would improve the short-term setup, while a close below Rs 578.52 would shift attention to the next support.

12 Month Indegene Target Price for 2027

The 12-month target for Indegene is Rs 615: forward EPS of Rs 17.47 at a PE of 35.20. That is 5.9% above Rs 580.90. It would still leave the stock 1.9% below its 52-week high of Rs 627.00.

How EPS Growth and PE Multiple Change the Indegene Target Price

EPS Growth	PE 28.16	PE 35.20	PE 40.48
0.0% (EPS Rs 16.64)	Rs 469	Rs 586	Rs 674
5.0% (EPS Rs 17.47)	Rs 492	Rs 615	Rs 707
11.0% (EPS Rs 18.47)	Rs 520	Rs 650	Rs 748

Each cell multiplies the forward EPS estimate by the PE shown. Reading across a row shows what a de-rating or re-rating does to the Indegene price forecast, and reading down a column shows what earnings growth is worth at a fixed multiple.

Bull Case and Downside Risk for Indegene Stock Target in 2027

Bull Case Rs 748

The bull case Indegene price target needs EPS growth of 11.0%, which lifts forward EPS to Rs 18.47, and a PE multiple that rises 15% to 40.48. That gives Rs 748, 28.8% above the current price and above the 52-week high of Rs 627.00, so the stock would have to set a fresh 52-week high.

Downside Risk Level Rs 469

The downside risk level is not a target. It assumes EPS stays flat at Rs 16.64 and the PE falls 20% to 28.16. That gives Rs 469, 19.3% below the current price and above the 52-week low of Rs 414.00.

Scenario	EPS Growth	PE Multiple	Price (Rs)	Change vs CMP
Bull Case	11.0%	40.48	Rs 748	+28.8%
Base Case	5.0%	35.20	Rs 615	+5.9%
Downside Risk	0.0%	28.16	Rs 469	-19.3%

Key Risks to the Indegene Target Price for 2027

Growth Slowdown Risk for the Indegene Price Target

Revenue in the June 2026 quarter was up 39.5% year on year, and FY26 revenue growth was 21.6%. If growth slows from here, the EPS estimate behind the Indegene stock target will need revising.

Liquidity and Size Risk

Indegene has a market capitalisation of Rs 14,110 crore. Institutional holding is 18.65%, and the latest filing shows no promoter holding. Stocks of this size are usually liquid, though exits can take longer than entries when the market is falling.

Valuation and Margin Risk

Net margin was 11.2% in FY26, and a squeeze from higher costs or weaker pricing would hit earnings first. At a PE of 35.20 versus an industry PE of 62.79, a de-rating toward the downside-risk PE of 28.16 would cut the price even if earnings hold.

Market and Technical Risk

The stock trades 7.4% below its 52-week high, with an RSI of 41.9 and a MACD reading below its signal line. Broader market weakness can override company fundamentals in the short term.

How to Invest in Indegene

Start with the live price and volume. Any Indegene share price target is only as current as the data behind it, and the data here is as of 9 October 2026, so refresh the Rs 580.90 price before acting on any level.

Next, review the fundamentals yourself. The Univest Screener lets you check Indegene's PE, ROE, debt and shareholding in one place.

Check Indegene fundamentals on the Univest Screener

Then compare the three Indegene target price scenarios with your own view. If you expect EPS growth below 5.0%, the base case is too optimistic for you; if you expect more, the bull case deserves weight.

Decide your position size and exit levels before you buy. The support and resistance levels above can serve as reference points, but they are not recommendations.

Finally, place the order through a SEBI-registered broker or the Univest app, and review the position after each quarterly result. Consult a SEBI-registered advisor if you are unsure.

Download the Univest iOS App or Univest Android App to track Indegene live price and get daily stock recommendations.

Conclusion

The Indegene share price target for 2027 is Rs 615 in the base case, with Rs 748 as the bull case. The support for that view is arithmetic you can check: EPS grew 5.0% a year over FY24 to FY26, and the stock trades at a PE of 35.20. The risks are equally concrete, including a stock that sits 7.4% below its 52-week high and a downside scenario that cuts the price 19% if earnings stall. Use these numbers as a framework, check them against the latest filings, and size any position to your own risk appetite.

FAQs on Indegene Share Price Target 2027

What is the Indegene share price target for 2027?

Ans. The base-case Indegene share price target for 2027 is Rs 615, with Rs 748 as the bull case. The downside risk level, which is not a target, is Rs 469. These are model estimates from reported earnings and the current PE, not guaranteed outcomes.

What is the Indegene share price today?

Ans. As of 9 October 2026, 3:29 PM IST, Indegene trades at Rs 580.90, down 0.90% on the day. The 52-week range is Rs 414.00 to Rs 627.00.

Is Indegene a buy or sell at the current price?

Ans. The data is mixed rather than one-sided: EPS has grown 5.0% a year over FY24 to FY26, but the stock is 7.4% below its 52-week high. Whether Indegene fits your portfolio depends on your time horizon and risk appetite, so consult a SEBI-registered advisor before investing. This article is not investment advice.

What are the bull case target and downside risk level for Indegene shares?

Ans. The bull case target is Rs 748, which assumes 11.0% EPS growth and a PE of 40.48. The downside risk level is Rs 469, which assumes flat EPS and a PE of 28.16. It marks a risk, not a target.

What are the main risks to the Indegene price target?

Ans. The main risks are slower revenue growth, a small market capitalisation of Rs 14,110 crore, a PE de-rating and short-term weakness in the broader market. Each is covered in the risk section above.

What is the PE ratio of Indegene and how does it compare with the industry?

Ans. The PE ratio of Indegene is 35.20 against an industry PE of 62.79. Price to book is 4.50 and return on equity is 12.78%. The base case in the Indegene price target holds this PE constant.

Who owns Indegene, and what is the promoter holding?

Ans. The latest filing shows no promoter holding in Indegene. FII held 9.91%, DII held 8.74% and the public held 81.34%.

What were Indegene's latest quarterly results?

Ans. In the June 2026 quarter, Indegene reported revenue of Rs 1,092 crore (up 39.5% year on year) and net profit of Rs 116.20 crore (down 0.2%).